February 2016 Edition Vol.11, Issue 2

Featured Articles

February 2016Edition

Some of the more under-the-radar success stories at ASH were a handful of clinical studies focused on targeted therapies that showed real promise for patients with hard-to-treat blood cancers. Improved survival, and expanded treatment options for pa...

One of the most exciting developments in cancer is the advent of liquid biopsies. But the way forward is fraught with questions, including which patients might benefit most, which tumors should be tested, and proof of clinical utility. As our artic...